The Role of Eukaryotic Translation Initiation Factor 6 in Tumors

Overview

Journal Oncol Lett

Specialty Oncology

Date 2017 Jul 12

PMID 28693127

Citations 11

Authors

Wei Zhu

Gui Xian Li

Hong Lang Chen

Xing Yan Liu

Affiliations

Soon will be listed here.

Abstract

Eukaryotic translation initiation factor 6 (eIF6) affects the maturation of 60S ribosomal subunits. Found in yeast and mammalian cells, eIF6 is primarily located in the cytoplasm of mammalian cells. Emerging evidence has demonstrated that the dysregulated expression of eIF6 is important in several types of human cancer, including head and neck carcinoma, colorectal cancer, non-small cell lung cancer and ovarian serous adenocarcinoma. However, the molecular mechanisms by which eIF6 functions during tumor formation and progression remain elusive. The present review focuses on recent progress in terms of the mechanisms and functions of eIF6 in human tumorigenesis or cancer cell lines, along with the signal transduction pathways in which this novel translation initiation factor may participate. Oncogenic Ras activates Notch-1 and promotes transcription of eIF6 via a recombining binding protein suppressor of Hairless-dependent mechanism. In addition, overexpression of eIF6 results in aberrant activation of the Wnt/β-catenin signaling pathway. Similarly, overexpressed eIF6 regulates its downstream modulator, cell division control protein 42, which in turn affects oncogenesis. Finally, the potential of eIF6 as a biomarker for diagnosis of cancer is also discussed in the present review.

Citing Articles

eIF6 modulates skin wound healing by upregulating keratin 6B.

Wang X, Xu G, Zhang F, Wei Y, Deng J, Mu L Stem Cells Transl Med. 2024; 13(11):1101-1112.

PMID: 39406496 PMC: 11555475. DOI: 10.1093/stcltm/szae064.

eIF6 Promotes Gastric Cancer Proliferation and Invasion by Regulating Cell Cycle.

Huang C, Zhou X, Zheng A, Luo X, Shen J, Xiao Z Dig Dis Sci. 2024; 69(9):3249-3260.

PMID: 38987443 PMC: 11415431. DOI: 10.1007/s10620-024-08464-z.

Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway.

Zhao Z, Chu W, Zheng Y, Wang C, Yang Y, Xu T Cell Commun Signal. 2021; 19(1):121.

PMID: 34922580 PMC: 8684100. DOI: 10.1186/s12964-021-00800-4.

Eukaryotic translation initiation factors as promising targets in cancer therapy.

Hao P, Yu J, Ward R, Liu Y, Hao Q, An S Cell Commun Signal. 2020; 18(1):175.

PMID: 33148274 PMC: 7640403. DOI: 10.1186/s12964-020-00607-9.

Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.

Roy S, Kumar R, Mittal V, Gupta D Sci Rep. 2020; 10(1):4113.

PMID: 32139710 PMC: 7057992. DOI: 10.1038/s41598-020-60740-w.

References

Tang C, Yuan S, Yang H, Wang Q, Zhang R . [Expression and significance of P311 and ITGB4BP in non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi. 2010; 32(7):526-8. View

Duvvuri U, Myers J . Cancer of the head and neck is the sixth most common cancer worldwide. Curr Probl Surg. 2008; 46(2):114-7. DOI: 10.1067/j.cpsurg.2008.10.002. View

Reymond N, Riou P, Ridley A . Rho GTPases and cancer cell transendothelial migration. Methods Mol Biol. 2011; 827:123-42. DOI: 10.1007/978-1-61779-442-1_9. View

Peters S, Adjei A, Gridelli C, Reck M, Kerr K, Felip E . Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23 Suppl 7:vii56-64. DOI: 10.1093/annonc/mds226. View

Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer S, Zlobin A . Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med. 2002; 8(9):979-86. DOI: 10.1038/nm754. View

Mondal N, Roychoudhury S, Ray M . Higher AgNOR Expression in Metaplastic and Dysplastic Airway Epithelial Cells Predicts the Risk of Developing Lung Cancer in Women Chronically Exposed to Biomass Smoke. J Environ Pathol Toxicol Oncol. 2015; 34(1):35-51. DOI: 10.1615/jenvironpatholtoxicoloncol.2015010708. View

Li V, Ng S, Boersema P, Low T, Karthaus W, Gerlach J . Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell. 2012; 149(6):1245-56. DOI: 10.1016/j.cell.2012.05.002. View

TANNER M, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T . Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res. 2000; 6(5):1833-9. View

Ferreira M, de Souza J, Cohen E . Role of molecular markers in the management of head and neck cancers. Curr Opin Oncol. 2011; 23(3):259-64. DOI: 10.1097/CCO.0b013e328344f53a. View

10.

Polakis P . Drugging Wnt signalling in cancer. EMBO J. 2012; 31(12):2737-46. PMC: 3380214. DOI: 10.1038/emboj.2012.126. View

11.

Niehrs C, Acebron S . Mitotic and mitogenic Wnt signalling. EMBO J. 2012; 31(12):2705-13. PMC: 3380213. DOI: 10.1038/emboj.2012.124. View

12.

Grosso S, Pesce E, Brina D, Beugnet A, Loreni F, Biffo S . Sensitivity of global translation to mTOR inhibition in REN cells depends on the equilibrium between eIF4E and 4E-BP1. PLoS One. 2012; 6(12):e29136. PMC: 3245250. DOI: 10.1371/journal.pone.0029136. View

13.

Cope C, Gilley R, Balmanno K, Sale M, Howarth K, Hampson M . Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation. J Cell Sci. 2013; 127(Pt 4):788-800. DOI: 10.1242/jcs.137588. View

14.

Ristola M, Arpiainen S, Shimokawa T, Ra C, Tienari J, Saleem M . Regulation of nephrin gene by the Ets transcription factor, GA-binding protein. Nephrol Dial Transplant. 2012; 28(4):846-55. DOI: 10.1093/ndt/gfs482. View

15.

Pinzaglia M, Montaldo C, Polinari D, Simone M, La Teana A, Tripodi M . EIF6 over-expression increases the motility and invasiveness of cancer cells by modulating the expression of a critical subset of membrane-bound proteins. BMC Cancer. 2015; 15:131. PMC: 4381359. DOI: 10.1186/s12885-015-1106-3. View

16.

Leemans C, Braakhuis B, Brakenhoff R . The molecular biology of head and neck cancer. Nat Rev Cancer. 2010; 11(1):9-22. DOI: 10.1038/nrc2982. View

17.

Cruciat C . Casein kinase 1 and Wnt/β-catenin signaling. Curr Opin Cell Biol. 2014; 31:46-55. DOI: 10.1016/j.ceb.2014.08.003. View

18.

Ranganathan P, Weaver K, Capobianco A . Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011; 11(5):338-51. DOI: 10.1038/nrc3035. View

19.

Furic L, Rong L, Larsson O, Koumakpayi I, Yoshida K, Brueschke A . eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc Natl Acad Sci U S A. 2010; 107(32):14134-9. PMC: 2922605. DOI: 10.1073/pnas.1005320107. View

20.

Winzer K, Bellach J, Hufnagl P . Long-term analysis to objectify the tumour grading by means of automated microscopic image analysis of the nucleolar organizer regions (AgNORs) in the case of breast carcinoma. Diagn Pathol. 2013; 8:56. PMC: 3640910. DOI: 10.1186/1746-1596-8-56. View